Dr. Curtis McMurtrey earned PhD in both Microbiology and Immunology. His studies included immune responses to Tuberculosis, Dengue virus, T. gondii, and HIV.
Currently He is the Director of Immunoproteomics at PureMHC. Up until recently they’ve worked on designing vaccines for certain types of cancer. When COVID hit pharma switched gears to study SARS-CoV-2.
In this episode we go into detail about the virus, mask efficiency, issues around ventilation, common misconceptions, latest research implications, latest updates on vaccines and when they may be available, and returning back to school from an immunologist perspective.